Back to MORGAN STANLEY MORGAN STANLEY

TORCNTORCN
Showing 6 of 7 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in ADICET BIO INC

As of its Q3 2025 13F, Morgan Stanley held 73,682 shares of TORCN (Adicet Bio), worth $59,697. Morgan Stanley's 13F filings listed TORCN from Q2 2024 to Q3 2025, 6 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$387,229

Total Shares Change

-268,909

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%—
0
2025-Q3
Increased
73,682
+2.0%
$59,6970.0%—
14
2025-Q2
Increased
72,226
+4191.5%
$44,0590.0%—
22
2025-Q1
Decreased
1,683
-78.8%
$1,2710.0%—
0
2024-Q4
Decreased
7,925
-97.0%
$7,6240.0%—
0
2024-Q3
Decreased
268,909
-75.9%
$387,2290.0%—
0

Other major holders of TORCN: RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used